AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveysView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, GeorgiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in UkraineView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Dynamics and peculiarities of AIDS mortality in Minsk, BelarusView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort studyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Prevalence of undiagnosed HBV infection in patients with COVID-19View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 countView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Post-discharge mortality among hospitalized HIV positive personsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi GeorgiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general populationView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Prevalence of hyperglycemia and its impact on mortality among HIV patients in GeorgiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targetsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Surveillance of recent HIV infection in Georgia, 2018-2020View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIVView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19A series of cases of HIV and acute Hepatitis B coinfection – treatment issuesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Progress in roll-out of generic dolutegravir-based treatment in GeorgiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Avidity of antibodies to Hepatitis C virus in persons with newly diagnosed HCV infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Latvia on its’ way to achieve WHO plan to eliminate Hepatitis C by 2030View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Co-infections with Hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern RomaniaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from UkraineView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Occult HBV infection and two clinical cases with malignant comorbiditiesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Randomized control trial of home-based Hepatitis C self-testing in key populations in GeorgiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCOVID-19Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patientView Abstract
